The sixth call for applications under the GACD banner focused on implementation research proposals targeting strategies to address primary and/or secondary prevention of cancer in Low- and Middle-Income Countries (LMICs) and in underserved populations facing health disparities, including Indigenous Populations, in High-Income Countries (HICs).
Please note this call is now closed
Find out more about the projects funded through the Cancer Prevention call.
Sixth GACD Funding Call – Primary and Secondary Prevention of Cancer
Cancer is becoming one of the most important public health problems worldwide and a leading cause of premature death. In 2018, an estimated 18.1 million people were diagnosed with cancer and 9.6 million died from it. Predictions suggest that 30 million people will die from cancer each year by 2030, of which 75% will be in LMICs. This increase may be attributed to aging societies, high prevalence of cancer risk behaviours, as well as the epidemiologic transition and socio-economic inequalities that result in untimely care seeking, care provision and poor quality care in many LMIC settings.
One-third of global cancer deaths are attributable to behavioural risk factors, such as tobacco and alcohol use, low fruit and vegetable intake, obesity and lack of physical activity. Tobacco use alone accounts for around 22% of cancer mortality, while alcohol use is associated with at least seven types of cancer, including breast and colorectal cancer. Around 25% of cancer incidence in LMICs is attributable to vaccine-preventable infections such as HPV and HBV.
Programme objectives
The long term goal was for the results of projects supported by this funding opportunity to provide healthcare providers and decision-makers with the scientific evidence to implement effective programs that would:
Advance local, regional or national cancer prevention and/or early diagnostic health policies, alleviating the global burden of cancer;
Improve affordability and tailor to local settings prevention and/or early diagnosis;
Establish the contextual effectiveness of cancer intervention(s) for prevention and/or early diagnosis, including at health systems level;
Provide evidence and recommendations to national programmes and policies focusing on prevention, screening, and/or early diagnosis;
Inform health service providers, policy and decision makers on effective scaling up of cancer interventions for prevention and/or early diagnosis at local, regional, and/or national levels, including affordability aspects for users and health providers;
Reduce health inequalities and inequities, including, but not limited to, consideration of characteristics such as socioeconomic circumstances, gender and age, where relevant in the prevention and/or early diagnosis of cancer at both local and/or global levels;
Maximise the use of existing relevant programmes and platforms (e.g. research, data, and delivery platforms);
Contribute to the United Nations’ Sustainable Development Goal 3.4.
Call text
Download the common call text agreed by the members of the GACD.
Funding agencies
The following funding agencies took part in the Cancer Prevention call:
National Health and Medical Research Council (NHMRC) Australia
Japan Agency for Medical Research and Development (AMED) Japan
National Institute for Health and Care Research (NIHR) United Kingdom
Outcomes
A total of 26 projects have been funded through the Cancer Prevention Programme to date.
You can also take a look at some of the publications and outputs from the projects funded through the Cancer call here.
Case studies
Would this content be useful for a friend or colleague?